Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Editorial: Immunotherapy for Tumor in the Brain: Insights From-and For-Other Tumor Sites.

Lampson LA.

Front Oncol. 2018 Apr 27;8:128. doi: 10.3389/fonc.2018.00128. eCollection 2018. No abstract available.

2.

Brain tumor immunotherapy: seeing the brain in the body.

Lampson LA.

Drug Discov Today. 2013 Apr;18(7-8):399-406. doi: 10.1016/j.drudis.2012.11.007. Epub 2012 Nov 27. Review.

PMID:
23195329
3.

Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.

Lampson LA.

MAbs. 2011 Mar-Apr;3(2):153-60. Epub 2011 Mar 1. Review.

4.

Targeted therapy for neuro-oncology: reviewing the menu.

Lampson LA.

Drug Discov Today. 2009 Feb;14(3-4):185-91. doi: 10.1016/j.drudis.2008.11.003. Epub 2008 Dec 26. Review.

PMID:
19063992
5.

Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.

Dutta T, Spence A, Lampson LA.

J Neurooncol. 2003 Aug-Sep;64(1-2):31-44.

PMID:
12952284
6.

Brain tumor immunotherapy: an immunologist's perspective.

Lampson LA.

J Neurooncol. 2003 Aug-Sep;64(1-2):3-11. Review.

PMID:
12952281
7.
8.

Local immune regulation in the central nervous system by substance P vs. glutamate.

McCluskey LP, Lampson LA.

J Neuroimmunol. 2001 Jun 1;116(2):136-46.

PMID:
11438168
9.

Local neurochemicals and site-specific immune regulation in the CNS.

McCluskey LP, Lampson LA.

J Neuropathol Exp Neurol. 2000 Mar;59(3):177-87. Review.

PMID:
10744056
10.
11.
12.

Beyond inflammation: site-directed immunotherapy.

Lampson LA.

Immunol Today. 1998 Jan;19(1):17-22. Review. No abstract available.

PMID:
9465483
13.
15.

Enhanced T cell migration to sites of microscopic CNS disease: complementary treatments evaluated by 2- and 3-D image analysis.

Lampson LA, Chen A, Vortmeyer AO, Sloan AE, Ghogawala Z, Kim L.

Brain Pathol. 1994 Apr;4(2):125-34. Review.

PMID:
8061858
16.
17.

Class I and II MHC expression and its implications for regeneration in the nervous system.

Lampson LA, Grabowska A, Whelan JP.

Prog Brain Res. 1994;103:307-17. Review. No abstract available.

PMID:
7886215
18.
20.

Disseminating tumor cells and their interactions with leukocytes visualized in the brain.

Lampson LA, Wen P, Roman VA, Morris JH, Sarid JA.

Cancer Res. 1992 Feb 15;52(4):1018-25.

23.
24.

Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.

Kassis AI, Van den Abbeele AD, Wen PY, Baranowska-Kortylewicz J, Aaronson RA, DeSisto WC, Lampson LA, Black PM, Adelstein SJ.

Cancer Res. 1990 Aug 15;50(16):5199-203.

28.
29.
30.

Defining the mechanisms that govern immune acceptance or rejection of neural tissue.

Lampson LA, Siegel G.

Prog Brain Res. 1988;78:243-7. No abstract available.

PMID:
3247427
31.

Functional implications of class I MHC modulation in neural tissue.

Lampson LA, Whelan JP, Siegel G.

Ann N Y Acad Sci. 1988;540:479-82. No abstract available.

PMID:
3207280
32.

Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis.

Lavi E, Suzumura A, Lampson LA, Siegel RM, Murasko DM, Silberberg DH, Weiss SR.

Adv Exp Med Biol. 1987;218:219-22.

PMID:
2829530
33.
37.

Molecular specificity of defined types of amacrine synapse in cat retina.

Sterling P, Lampson LA.

J Neurosci. 1986 May;6(5):1314-24.

38.
39.

Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes.

Main EK, Lampson LA, Hart MK, Kornbluth J, Wilson DB.

J Immunol. 1985 Jul;135(1):242-6.

PMID:
3158702
40.
41.

Immunoblot specificity of monoclonal antibodies assayed against complex extracts.

Lampson LA, Fisher CA.

Anal Biochem. 1985 Jan;144(1):55-64.

PMID:
2580457
42.
43.

Monoclonal antibodies against the voltage-sensitive Na+ channel from mammalian skeletal muscle.

Casadei JM, Gordon RD, Lampson LA, Schotland DL, Barchi RL.

Proc Natl Acad Sci U S A. 1984 Oct;81(19):6227-31.

44.

Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

Lampson LA, Fisher CA, Whelan JP.

J Immunol. 1983 May;130(5):2471-8.

PMID:
6187860
45.

Separation of three class II antigens from a homozygous human B cell line.

Shackelford DA, Lampson LA, Strominger JL.

J Immunol. 1983 Jan;130(1):289-96.

PMID:
6600185
46.

Paucity of HLA-A,B,C molecules on human cells of neuronal origin: microscopic analysis of neuroblastoma cell lines and tumor.

Lampson LA, Whelan JP.

Ann N Y Acad Sci. 1983;420:107-14. No abstract available.

PMID:
6586091
47.

Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.

Shaw S, DeMars R, Schlossman SF, Smith PL, Lampson LA, Nadler LM.

J Exp Med. 1982 Sep 1;156(3):731-43.

48.
49.

Two populations of Ia-like molecules on a human B cell line.

Lampson LA, Levy R.

J Immunol. 1980 Jul;125(1):293-9.

PMID:
6966655
50.

A role for clonal antigens in cancer diagnosis and therapy.

Lampson LA, Levy R.

J Natl Cancer Inst. 1979 Feb;62(2):217-20. Review. No abstract available.

PMID:
84087

Supplemental Content

Loading ...
Support Center